Beam Therapeutics Inc. monthly returns
Beam Therapeutics Inc. has averaged 0.21% per month, positive in 49% of months. Month-by-month returns for Beam Therapeutics Inc. (BEAM) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Beam Therapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -4.0% | |
| Sep 2026 | -16.9% | |
| Aug 2026 | +15.3% | |
| Jul 2026 | -25.6% | |
| Jun 2026 | +4.2% | |
| May 2026 | +8.6% | |
| Apr 2026 | +27.3% | |
| Mar 2026 | -16.3% | |
| Feb 2026 | +3.0% | |
| Jan 2026 | -0.4% | |
| Dec 2025 | +9.4% | |
| Nov 2025 | +1.3% | |
| Oct 2025 | +3.0% | |
| Sep 2025 | +48.3% | |
| Aug 2025 | -17.0% | |
| Jul 2025 | +15.9% | |
| Jun 2025 | +7.5% | |
| May 2025 | -20.6% | |
| Apr 2025 | +2.0% | |
| Mar 2025 | -25.9% | |
| Feb 2025 | +1.6% | |
| Jan 2025 | +4.5% | |
| Dec 2024 | -9.4% | |
| Nov 2024 | +24.9% | |
| Oct 2024 | -10.6% | |
| Sep 2024 | -8.2% | |
| Aug 2024 | -15.7% | |
| Jul 2024 | +35.0% | |
| Jun 2024 | -1.6% | |
| May 2024 | +12.3% | |
| Apr 2024 | -35.8% | |
| Mar 2024 | -16.3% | |
| Feb 2024 | +61.8% | |
| Jan 2024 | -10.4% | |
| Dec 2023 | -3.1% | |
| Nov 2023 | +32.8% | |
| Oct 2023 | -12.1% | |
| Sep 2023 | +3.8% | |
| Aug 2023 | -24.9% | |
| Jul 2023 | -3.3% | |
| Jun 2023 | +0.1% | |
| May 2023 | +3.9% | |
| Apr 2023 | +0.3% | |
| Mar 2023 | -23.9% | |
| Feb 2023 | -7.4% | |
| Jan 2023 | +11.1% | |
| Dec 2022 | -15.3% | |
| Nov 2022 | +4.8% | |
| Oct 2022 | -7.5% | |
| Sep 2022 | -12.7% | |
| Aug 2022 | -13.3% | |
| Jul 2022 | +62.7% | |
| Jun 2022 | +10.0% | |
| May 2022 | -6.3% | |
| Apr 2022 | -34.5% | |
| Mar 2022 | -26.9% | |
| Feb 2022 | +13.2% | |
| Jan 2022 | -13.2% | |
| Dec 2021 | +0.7% | |
| Nov 2021 | -10.8% | |
| Oct 2021 | +2.0% | |
| Sep 2021 | -21.6% | |
| Aug 2021 | +20.6% | |
| Jul 2021 | -28.5% | |
| Jun 2021 | +64.5% | |
| May 2021 | -4.6% | |
| Apr 2021 | +2.4% | |
| Mar 2021 | -10.2% | |
| Feb 2021 | -7.6% | |
| Jan 2021 | +18.1% | |
| Dec 2020 | +63.3% | |
| Nov 2020 | +46.3% | |
| Oct 2020 | +38.8% | |
| Sep 2020 | -2.0% | |
| Aug 2020 | +29.8% | |
| Jul 2020 | -30.9% | |
| Jun 2020 | +9.6% | |
| May 2020 | +60.2% | |
| Apr 2020 | -11.4% | |
| Mar 2020 | -20.0% |
Monthly total return (since Nov 2021)#
Beam Therapeutics Inc. returns by calendar month#
Every month of every year since 2021, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -4.01% — 3rd of 6 Octobers since 2021 at the last close; the average October returned -5.0%.
| Month | −65%0+65% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +1.6% | +2.1% | 50% | +18.1% 2021 | -13.2% 2022 | |
| Feb | +10.8% | +2.3% | 67% | +61.8% 2024 | -7.6% 2021 | |
| Mar | -19.9% | -20.1% | 0% | -10.2% 2021 | -26.9% 2022 | |
| Apr | -6.4% | +1.2% | 67% | +27.3% 2026 | -35.8% 2024 | |
| May | -1.1% | -0.4% | 50% | +12.3% 2024 | -20.6% 2025 | |
| Jun | +14.1% | +5.8% | 83% | +64.5% 2021 | -1.6% 2024 | |
| Jul | +9.4% | +6.3% | 50% | +62.7% 2022 | -28.5% 2021 | |
| Aug | -5.8% | -14.5% | 33% | +20.6% 2021 | -24.9% 2023 | |
| Sep | -1.2% | -10.5% | 33% | +48.3% 2025 | -21.6% 2021 | |
| Oct | -5.0% | -7.5% | 40% | +3.0% 2025 | -12.1% 2023 | |
| Nov | +10.6% | +4.8% | 80% | +32.8% 2023 | -10.8% 2021 | |
| Dec | -3.5% | -3.1% | 40% | +9.4% 2025 | -15.3% 2022 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from BEAM's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Beam Therapeutics Inc.'s average monthly return?
- Beam Therapeutics Inc. (BEAM) has averaged about 0.21% per month, positive in roughly 49% of months. The best month was Jun 2021 (+64.5%) and the worst was Apr 2024 (-35.8%).